On August 22, 2023, the Sichuan Provincial Department of Economy and Information Technology announced the Public Notice on the Proposed List of Sichuan Province’s Specialized, Sophisticated, Distinctive, and Innovative SMEs for 2023. Chengdu Shibeikang Biomedical Technology Co., Ltd. has been proudly selected for this prestigious list.

微信图片_20250610112748.jpg


In recent years, the term “Specialized, Sophisticated, Distinctive, and Innovative” has gained significant traction, and there is growing recognition of its importance as a development model for small and medium-sized enterprises (SMEs). These companies are seen as the driving force behind high-quality industrial development, and play a critical role in innovation and technological advancement.

What are Specialized, Sophisticated, Distinctive, and Innovative SMEs?
These SMEs are characterized by: A strong alignment with national industrial policies and goals; significant technological innovation and solid financial capabilities; a dominant market share and expertise in mastering key technologies; fast growth and outstanding efficiency; an essential role in industrial and supply chains, following a path defined by specialization, refinement, uniqueness, and novelty.

What’s Next for Our Company?
Guiding small and medium-sized enterprises (SMEs) toward a path of specialization, refinement, and innovation is a national imperative for achieving high-quality development within the SME sector. Looking ahead, SBK will continue to embody its core values of “Empowering Better Health Through Inclusive Care and Support” by driving innovation, increasing R&D investment, and advancing technological development. We will focus on key areas such as cardiovascular, cerebrovascular, and respiratory diseases to develop even more differentiated and innovative drugs with superior metabolic properties. By strengthening our specialized, sophisticated, distinctive, and innovative capabilities, we are set to achieve sustainable, high-quality growth!